Intercept Pharmaceuticals
Earnings Date & Report
Last updated:
Intercept Pharmaceuticals’s last earnings date was on 31 Jul 2024.
Intercept Pharmaceuticals stock Earnings report, Estimates & History
| 2019-11-05 | -2.35 | -2.59 |
|---|---|---|
| 2020-02-25 | -2.56 | -2.99 |
| 2020-05-11 | -2.94 | -2.86 |
| 2020-08-10 | -2.94 | -1.92 |
| 2020-11-09 | -1.96 | -2.01 |
| 2021-02-25 | -1.55 | -1.58 |
| 2021-05-06 | -1.53 | -1.22 |
| 2021-07-29 | -1.24 | -0.33 |
| 2021-11-03 | -1 | -0.63 |
| 2022-03-02 | -1.26 | -1.23 |
| 2022-05-06 | -0.89 | -0.58 |
| 2022-08-03 | -0.53 | -0.68 |
| 2022-11-01 | 5.11 | -3.04 |
| 2023-03-02 | -0.53 | -0.42 |
| 2023-04-27 | -0.57 | -0.77 |
| 2023-08-02 | -0.56 | -0.14 |
| 2023-11-07 | -0.27 | -0.07 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Intercept Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 31 Jul 2024 | N/A | N/A | N/A | N/A | N/A | |
| 25 Apr 2024 | N/A | N/A | N/A | N/A | N/A | |
| 7 Mar 2024 | N/A | -$0.02 | N/A | N/A | N/A | |
| 7 Nov 2023 | Beat | -$0.27 | -$0.07 | 90.66M | 88.78M | |
| 2 Aug 2023 | Beat | -$0.56 | -$0.14 | 79.57M | 83.71M | Earnings Call Transcript |
| 27 Apr 2023 | Missed | -$0.57 | -$0.77 | 80.35M | 67.95M | Earnings Call Transcript |
| 2 Mar 2023 | Beat | -$0.53 | -$0.42 | 74.07M | 77.21M | Earnings Call Transcript |
| 1 Nov 2022 | Missed | $5.11 | -$3.04 | N/A | 77.58M | Earnings Call Transcript |
| 3 Aug 2022 | Missed | -$0.53 | -$0.68 | N/A | 71.75M | Earnings Call Transcript |
| 6 May 2022 | Beat | -$0.89 | -$0.58 | 120.07M | 88.58M | Earnings Call Transcript |
| 2 Mar 2022 | Beat | -$1.26 | -$1.23 | 90.63M | 92.40M | Earnings Call Transcript |
| 3 Nov 2021 | Beat | -$1 | -$0.63 | 81.81M | 92.82M | Earnings Call Transcript |
| 29 Jul 2021 | Beat | -$1.24 | -$0.33 | 82.68M | 96.57M | Earnings Call Transcript |
| 6 May 2021 | Beat | -$1.53 | -$1.22 | 81.14M | 81.66M | |
| 25 Feb 2021 | Missed | -$1.55 | -$1.58 | 85.01M | 83.26M | Earnings Call Transcript |
| 9 Nov 2020 | Missed | -$1.96 | -$2.01 | 76.22M | 79.52M | |
| 10 Aug 2020 | Beat | -$2.94 | -$1.92 | 117.48M | 77.24M | Earnings Call Transcript |
| 11 May 2020 | Beat | -$2.94 | -$2.86 | 73.66M | 72.65M | Earnings Call Transcript |
| 25 Feb 2020 | Missed | -$2.56 | -$2.99 | 63.84M | 71.5M | Earnings Call Transcript |
| 5 Nov 2019 | Missed | -$2.35 | -$2.59 | 58.12M | 61.95M | Earnings Call Transcript |
Intercept Pharmaceuticals Earnings report FAQs
When is Intercept Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest Intercept Pharmaceuticals's earnings date was on 2 Aug 2023.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.